Hale Ateş

1.2k total citations
25 papers, 154 citations indexed

About

Hale Ateş is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Hale Ateş has authored 25 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 5 papers in Surgery. Recurrent topics in Hale Ateş's work include Asthma and respiratory diseases (6 papers), Drug-Induced Adverse Reactions (5 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Hale Ateş is often cited by papers focused on Asthma and respiratory diseases (6 papers), Drug-Induced Adverse Reactions (5 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Hale Ateş collaborates with scholars based in Türkiye, Kuwait and Iceland. Hale Ateş's co-authors include İhsan Ateş, Harun Kundi, Fatma Meriç Yılmaz, Kurtuluş Aksu, Ferda Öner Erkekol, Özlem Özdedeoğlu, Hüseyin Çelik, Bülent Bozkurt, Duygu Özol and Selma Fırat and has published in prestigious journals such as Medicine, Inflammatory Bowel Diseases and The American Journal of Emergency Medicine.

In The Last Decade

Hale Ateş

19 papers receiving 143 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hale Ateş Türkiye	8	35	35	33	25	24	25	154
Nabil Belfeki France	9	5 0.1×	22 0.6×	9 0.3×	45 1.8×	22 0.9×	49	220
Laura Wiffen United Kingdom	6	8 0.2×	17 0.5×	15 0.5×	29 1.2×	40 1.7×	13	170
Hani Kozman United States	9	20 0.6×	8 0.2×	6 0.2×	57 2.3×	59 2.5×	22	341
François-Xavier Lapébie France	7	45 1.3×	3 0.1×	10 0.3×	32 1.3×	14 0.6×	23	149
Irzal Hadžibegović Croatia	8	35 1.0×	10 0.3×	51 1.5×	19 0.8×	8 0.3×	34	186
Emilia Parodi Italy	10	19 0.5×	13 0.4×	7 0.2×	34 1.4×	25 1.0×	28	268
Allen Lim Canada	5	4 0.1×	32 0.9×	16 0.5×	20 0.8×	22 0.9×	14	372
Benjamin Debuc France	3	6 0.2×	6 0.2×	19 0.6×	44 1.8×	9 0.4×	3	144
Xuefeng Sun China	9	17 0.5×	32 0.9×	31 0.9×	95 3.8×	7 0.3×	28	254
Poorva Bindal United States	5	92 2.6×	2 0.1×	93 2.8×	14 0.6×	8 0.3×	16	258

Countries citing papers authored by Hale Ateş

Since Specialization

Citations

This map shows the geographic impact of Hale Ateş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hale Ateş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hale Ateş more than expected).

Fields of papers citing papers by Hale Ateş

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hale Ateş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hale Ateş. The network helps show where Hale Ateş may publish in the future.

Co-authorship network of co-authors of Hale Ateş

This figure shows the co-authorship network connecting the top 25 collaborators of Hale Ateş. A scholar is included among the top collaborators of Hale Ateş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hale Ateş. Hale Ateş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Erkekol, Ferda Öner, et al.. (2024). Hypersensitivity reactions with first-line antituberculosis drugs and outcomes of rapid desensitizations. World Allergy Organization Journal. 17(1). 100862–100862. 2 indexed citations

Özdedeoğlu, Özlem, et al.. (2024). What is the Best Way to Diagnose Possible Asthma Patients with Negative Bronchodilator Reversibility Tests?. Journal of Asthma and Allergy. Volume 17. 113–122.

Eki̇ci̇, Mehmet, et al.. (2024). Mastitis in Sheep - Procalcitonin Level as a Biomarker for Early Diagnosis. ACTA SCIENTIAE VETERINARIAE. 52.

Aksu, Kurtuluş, et al.. (2023). Characteristics of adverse reactions due to subcutaneous allergen immunotherapy applied between 2011-2021: Single center experience. Tuberkuloz ve Toraks. 71(4). 356–366.

Ateş, Hale, et al.. (2023). Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions. Allergologia et Immunopathologia. 51(2). 130–136. 1 indexed citations

Ateş, Hale, et al.. (2022). A favipiravir-induced angioedema and urticaria in a COVID-19 patient. Antiviral Therapy. 27(6). 3867489286–3867489286.

Aksu, Kurtuluş, et al.. (2021). COVID-19 in patients with severe asthma using biological agents. Tuberkuloz ve Toraks. 69(3). 433–436. 10 indexed citations

Ateş, Hale, et al.. (2021). Identification of Risk Factors and Cross-Reactivity of Local Anesthetics Hypersensitivity: Analysis of 14-Years’ Experience. Journal of Asthma and Allergy. Volume 14. 47–58. 16 indexed citations

Ateş, Hale, et al.. (2021). Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic. World Allergy Organization Journal. 14(7). 100558–100558. 7 indexed citations

10.

Aksu, Kurtuluş, et al.. (2021). COVID-19 in a patient with severe asthma using mepolizumab. Allergy and Asthma Proceedings. 42(2). e55–e57. 21 indexed citations

11.

Aksu, Kurtuluş, et al.. (2021). Mycobacterium abscessus enfeksiyonu yönetimi: Makrolid ve kinolon desensitizasyonu. Tuberkuloz ve Toraks. 69(3). 399–402.

12.

Ateş, Hale, et al.. (2021). Direct cost analysis for patients with severe asthma receiving omalizumab treatment. Journal of Health Sciences and Medicine. 4(5). 735–740.

13.

Özdedeoğlu, Özlem, et al.. (2020). Successful Desensitization with Ferric Carboxymaltose. 18(1). 51–53. 1 indexed citations

14.

Ateş, Hale, et al.. (2017). A novel clinical index for the assessment of RVD in acute pulmonary embolism: Blood pressure index. The American Journal of Emergency Medicine. 35(10). 1400–1403. 4 indexed citations

15.

Ateş, Hale, İhsan Ateş, Harun Kundi, & Fatma Yılmaz. (2016). Choice of marker for assessment of RV dysfunction in acute pulmonary embolism. Herz. 42(8). 758–765. 3 indexed citations

16.

Ateş, İhsan, Nihal Özkayar, Hale Ateş, et al.. (2016). Elevated circulating sST2 associated with subclinical atherosclerosis in newly diagnosed primary hypertension. Hypertension Research. 39(7). 513–518. 10 indexed citations

17.

Yüksel, Mahmut, Mustafa Kaplan, İhsan Ateş, et al.. (2016). The role of soluble tumor necrosis factor like weak inducer of apoptosis and interleukin-17A in the etiopathogenesis of celiac disease. Medicine. 95(26). e3937–e3937. 1 indexed citations

18.

Ateş, İhsan, et al.. (2016). Squamous Cell Cancer of The Lung with Synchronous Renal Cell Carcinoma. PubMed. 17(3). 125–127. 2 indexed citations

19.

Kaplan, Mustafa, et al.. (2015). Are sTWEAK and IL-17A Levels in Inflammatory Bowel Disease Associated with Disease Activity and Etiopathogenesis?. Inflammatory Bowel Diseases. 22(3). 615–622. 8 indexed citations

20.

Ateş, Hale, et al.. (2015). What is the most reliable marker in the differential diagnosis of pulmonary embolism and community-acquired pneumonia?. Blood Coagulation & Fibrinolysis. 27(3). 252–258. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact